Through the Duke KURe program, Duke University provides structured mentoring, customized research training, and individualized career development for early career level MD, PhD, and MD/PhD faculty and postdoctoral fellows who are committed to an independent research career in benign urology. During the past funding period, we have supported 6 KURe Scholars including 1 underrepresented minority. Three Scholars have acquired independent funding and we currently support 3 Duke KURe Scholars. This competitive renewal of the Duke KURe program continues our three major goals: 1) Foster diversity by identifying and recruiting scholars from diverse backgrounds and by providing individualized mentoring and career development support in an environment of team science. 2) Train the next generation of benign urology researchers by fostering multidisciplinary research emphasizing the importance of diverse scientific methods. 3) Prepare KURe Scholars to lead their own multidisciplinary research teams and become the mentors and leaders of tomorrow. At any one time, we plan to support three Scholars. Each Scholar chooses a KURe mentor from a core group of recognized senior investigators. A second mentor is chosen to maximize multidisciplinary opportunities and collaborations, and to support clinical, translational, and basic science approaches. The Duke KURe mentors have significant expertise in 4 main areas of benign urology: 1) Lower Urinary Tract Dysfunction, 2) Urinary Tract Infection/Inflammation, 3) Pediatric Urology, and 4) Stone Disease. In addition, our mentors employ different approaches and can guide our Scholars using 1) Basic/Translational Research, 2) Clinical Trials, 3) Health Services Research, and 4) Systems Biology. As part of the leadership team, the Duke KURe program includes an experienced faculty career coach, who designed the Leadership Enhancement and Career Development Coaching Program for KURe Scholars. This is a critical component of our successful program. The Duke KURe career development program spans two to five years depending on the Scholar?s educational needs. It consists of intense hands-on research, structured mentoring, didactic course work, seminars, and workshops on scientific and career development related subjects, and training in responsible conduct of research. At completion of the program, the Scholars are expected to have published in peer-reviewed journals and obtain independent funding. Scholars? progress is monitored by the Program Director and the Advisory Committee. Program leadership receives frequent feedback from both mentors and Scholars. Program improvements are made based on such feedback, recommendations by the career coach and the Advisory Committee, and the results from an independent external review. The Duke KURe is a successful, vibrant program that has expert mentors, experienced leadership, and the institutional commitment to ensure that a diverse pool of highly trained scientists is available to address benign urology through multidisciplinary collaborations.

Public Health Relevance

Duke University, a major research university in Durham, NC, supports a career development program focused on benign urologic conditions, a major public health concern. Early career scientists will receive formal mentoring and training to conduct multidisciplinary research relevant to benign urology. These well-trained scientists will become the future leaders researching the underlying causes of benign urologic conditions and developing better treatments.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Physician Scientist Award (Program) (PSA) (K12)
Project #
2K12DK100024-06
Application #
9647778
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Rankin, Tracy L
Project Start
2013-08-01
Project End
2023-09-13
Budget Start
2018-09-14
Budget End
2019-09-13
Support Year
6
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Duke University
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Hokanson, James A; Langdale, Christopher L; Sridhar, Arun et al. (2018) Stimulation of the sensory pudendal nerve increases bladder capacity in the rat. Am J Physiol Renal Physiol 314:F543-F550
Bradley, Megan S; Bickhaus, Jennifer A; Amundsen, Cindy L et al. (2018) Vaginal Uterosacral Ligament Suspension: A Retrospective Cohort of Absorbable and Permanent Suture Groups. Female Pelvic Med Reconstr Surg 24:207-212
Kelly, Maryellen S; Routh, Jonathan C; Davis, Leah G et al. (2018) Lower Urinary Tract Symptoms in Older Children With and Without Diabetes Mellitus. Clin Pediatr (Phila) 57:1576-1581
Arya, Lily A; Richter, Holly E; Jelovsek, Eric et al. (2018) Metabolites and microbial composition of stool of women with fecal incontinence: Study design and methods. Neurourol Urodyn 37:634-641
Bradley, Megan S; Burke, Emily E; Grenier, Carole et al. (2018) A genome-scale DNA methylation study in women with interstitial cystitis/bladder pain syndrome. Neurourol Urodyn 37:1485-1493
Kisby, Cassandra K; Gonzalez, Eric J; Visco, Anthony G et al. (2018) Randomized Controlled Trial to Assess the Impact of Intraurethral Lidocaine on Urodynamic Voiding Parameters. Female Pelvic Med Reconstr Surg :
Jiang, R; Kelly, M S; Routh, J C (2018) Assessment of pediatric bowel and bladder dysfunction: a critical appraisal of the literature. J Pediatr Urol 14:494-501
Bradley, Megan S; Boudreau, Marie-Helene; Grenier, Carole et al. (2017) Urine RNA Processing in a Clinical Setting: Comparison of 3 Protocols. Female Pelvic Med Reconstr Surg :
Langdale, Christopher L; Hokanson, James A; Sridhar, Arun et al. (2017) Stimulation of the pelvic nerve increases bladder capacity in the prostaglandin E2 rat model of overactive bladder. Am J Physiol Renal Physiol 313:F657-F665
Komesu, Yuko M; Richter, Holly E; Dinwiddie, Darrell L et al. (2017) Methodology for a vaginal and urinary microbiome study in women with mixed urinary incontinence. Int Urogynecol J 28:711-720

Showing the most recent 10 out of 33 publications